Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • harvard1
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
Contrast agent for early diagnostics and monitoring of progression of liver cancer (hepatocellular carcinoma)
KTH, School of Technology and Health (STH), Medical Engineering, Medical Imaging. Karolinska Institutet (KI), CLINTEC – Division of Medical Imaging and Technology. (Contrast Enhanced Medical Imaging)ORCID iD: 0000-0002-3699-396X
2013 (English)Conference paper, Oral presentation only (Refereed)
Place, publisher, year, edition, pages
2013.
National Category
Medical Laboratory and Measurements Technologies Medical Materials
Identifiers
URN: urn:nbn:se:kth:diva-137649OAI: oai:DiVA.org:kth-137649DiVA: diva2:679297
Conference
Nanoparticles for Early Diagnostics of Inflammatory Diseases: new approaches in the field of soft and hard nanoparticle, 20-21 November 2013, Lisboa, Portugal.
Note

QC 20140618

Available from: 2013-12-14 Created: 2013-12-14 Last updated: 2014-06-18Bibliographically approved

Open Access in DiVA

No full text

Authority records BETA

Grishenkov, Dmitry

Search in DiVA

By author/editor
Grishenkov, Dmitry
By organisation
Medical Imaging
Medical Laboratory and Measurements TechnologiesMedical Materials

Search outside of DiVA

GoogleGoogle Scholar

urn-nbn

Altmetric score

urn-nbn
Total: 75 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • harvard1
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf